142 related articles for article (PubMed ID: 28292200)
1. Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase.
Brusilow WS; Peters TJ
Expert Opin Ther Targets; 2017 May; 21(5):461-469. PubMed ID: 28292200
[TBL] [Abstract][Full Text] [Related]
2. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.
Ghoddoussi F; Galloway MP; Jambekar A; Bame M; Needleman R; Brusilow WS
J Neurol Sci; 2010 Mar; 290(1-2):41-7. PubMed ID: 20060132
[TBL] [Abstract][Full Text] [Related]
3. Identification of the isomer of methionine sulfoximine that extends the lifespan of the SOD1 G93A mouse.
Brusilow WS
Neurosci Lett; 2017 Apr; 647():165-167. PubMed ID: 28323087
[TBL] [Abstract][Full Text] [Related]
4. A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure.
Jambekar AA; Palma E; Nicolosi L; Rasola A; Petronilli V; Chiara F; Bernardi P; Needleman R; Brusilow WS
Liver Int; 2011 Sep; 31(8):1209-21. PubMed ID: 21745296
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte swelling in liver failure: role of glutamine and benzodiazepines.
Norenberg MD; Bender AS
Acta Neurochir Suppl (Wien); 1994; 60():24-7. PubMed ID: 7526622
[TBL] [Abstract][Full Text] [Related]
6. Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.
Cooper AJ
Metab Brain Dis; 2013 Jun; 28(2):119-25. PubMed ID: 23065027
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human glutamine synthetase by L-methionine-S,R-sulfoximine-relevance to the treatment of neurological diseases.
Jeitner TM; Cooper AJ
Metab Brain Dis; 2014 Dec; 29(4):983-9. PubMed ID: 24136581
[TBL] [Abstract][Full Text] [Related]
8. Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS.
Bame M; Pentiak PA; Needleman R; Brusilow WS
Gend Med; 2012 Dec; 9(6):524-35. PubMed ID: 23217569
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic differences between fast and slow methionine sulfoximine-inbred mice: seizures, anxiety, and glutamine synthetase.
Boissonnet A; Hévor T; Cloix JF
Epilepsy Res; 2012 Jan; 98(1):25-34. PubMed ID: 22050980
[TBL] [Abstract][Full Text] [Related]
10. [Methionine sulfoximine and phosphinothricin--glutamine synthetase inhibitors and activators and their herbicidal activity (A review)].
Evstigneeva ZG; Solov'eva NA; Sidel'nikova LI
Prikl Biokhim Mikrobiol; 2003; 39(6):613-8. PubMed ID: 14714472
[TBL] [Abstract][Full Text] [Related]
11. Effects of methionine sulfoximine on the glutamine and glutamate content and cell volume in rat cerebral cortical slices: involvement of mechanisms not related to inhibition of glutamine synthesis.
Zielińska M; Stafiej A; Law RO; Albrecht J
Neurotoxicology; 2004 Mar; 25(3):443-9. PubMed ID: 15019307
[TBL] [Abstract][Full Text] [Related]
12. Effects of site-specific infusions of methionine sulfoximine on the temporal progression of seizures in a rat model of mesial temporal lobe epilepsy.
Dhaher R; Wang H; Gruenbaum SE; Tu N; Lee TS; Zaveri HP; Eid T
Epilepsy Res; 2015 Sep; 115():45-54. PubMed ID: 26220375
[TBL] [Abstract][Full Text] [Related]
13. Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.
Fries AW; Dadsetan S; Keiding S; Bak LK; Schousboe A; Waagepetersen HS; Simonsen M; Ott P; Vilstrup H; Sørensen M
J Cereb Blood Flow Metab; 2014 Mar; 34(3):460-6. PubMed ID: 24346692
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with a glutamine synthetase inhibitor MSO delays the onset of initial seizures induced by pilocarpine in juvenile rats.
Pawlik MJ; Obara-Michlewska M; Popek MP; Czarnecka AM; Czuczwar SJ; Łuszczki J; Kołodziej M; Acewicz A; Wierzba-Bobrowicz T; Albrecht J
Brain Res; 2021 Feb; 1753():147253. PubMed ID: 33422530
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of Saccharomyces cerevisiae genes that confer L-methionine sulfoximine and tabtoxin resistance.
Marek ET; Dickson RC
J Bacteriol; 1987 Jun; 169(6):2440-8. PubMed ID: 2884208
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy.
Gruenbaum SE; Wang H; Zaveri HP; Tang AB; Lee TS; Eid T; Dhaher R
Epilepsy Behav; 2015 Oct; 51():96-103. PubMed ID: 26262937
[TBL] [Abstract][Full Text] [Related]
17. The non-proteinogenic amino acids L-methionine sulfoximine and DL-phosphinothricin activate mTOR.
Tardito S; Chiu M; Franchi-Gazzola R; Dall'Asta V; Comi P; Bussolati O
Amino Acids; 2012 Jun; 42(6):2507-12. PubMed ID: 21769496
[TBL] [Abstract][Full Text] [Related]
18. The effect of glial glutamine synthetase inhibition on recognition and temporal memories in the rat.
Kant D; Tripathi S; Qureshi MF; Tripathi S; Pandey S; Singh G; Kumar T; Mir FA; Jha SK
Neurosci Lett; 2014 Feb; 560():98-102. PubMed ID: 24370597
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutamine synthesis induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons.
Dadsetan S; Bak LK; Sørensen M; Keiding S; Vilstrup H; Ott P; Leke R; Schousboe A; Waagepetersen HS
Neurochem Int; 2011 Sep; 59(4):482-8. PubMed ID: 21397649
[TBL] [Abstract][Full Text] [Related]
20. Alteration of striatal glutamate release after glutamine synthetase inhibition.
Rothstein JD; Tabakoff B
J Neurochem; 1984 Nov; 43(5):1438-46. PubMed ID: 6149260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
